Cardiorenal outcomes, kidney function, and other safety outcomes with ertugliflozin in older adults with type 2 diabetes (VERTIS CV): secondary analyses from a randomised, double-blind trial Article

cited authors

  • Pratley, Richard E.; Cannon, Christopher P.; Cherney, David Z., I; Cosentino, Francesco; McGuire, Darren K.; Essex, Margaret Noyes; Lawrence, David; Jones, Philip L. S.; Liu, Jie; Adamsons, Ingrid; Dagogo-Jack, Samuel

authors

Publication Date

  • April 1, 2023

webpage

published in

category

start page

  • E143

end page

  • E154

volume

  • 4

issue

  • 4